Stay updated on Elranatamab in Refractory Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Elranatamab in Refractory Multiple Myeloma Clinical Trial page.

Latest updates to the Elranatamab in Refractory Multiple Myeloma Clinical Trial page
- Check7 days agoChange DetectedVersion 51 was submitted on 2025-12-02, adding updates to the Contacts/Locations and Study Status sections of the record history. A prior version (50) appears to have been deleted on 2025-10-20.SummaryDifference0.3%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page history now shows a new revision entry (v3.3.2) replacing the earlier v3.2.0; no substantive study data or status changes are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the government funding/operating status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check42 days agoChange DetectedRecord History page shows minor layout/formatting changes to the Version history list with no alteration to study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check71 days agoChange DetectedThe page now displays an updated government operating status notice and revision to v3.2.0, with a current date; an older date and v3.1.0 have been removed.SummaryDifference10%

- Check78 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.2%

Stay in the know with updates to Elranatamab in Refractory Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elranatamab in Refractory Multiple Myeloma Clinical Trial page.